Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 98 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer MOST POPULAR Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre... September 2, 2020 Grace and Love for Full Hands March 31, 2021 EMA Recommends Granting a Conditional Marketing Authorisation for Pralsetinib September 28, 2021 With 3 Years Minimum Follow-Up, Nivolumab Plus Ipilimumab Continues to Provide... February 9, 2022 Load more HOT NEWS Girls Aloud members to join forces to raise money in Sarah... Active Surveillance for Low-Risk Prostate Cancer Continues to Rise 8-Year-Old Cancer Survivor Celebrates Recovery By Donating Her Birthday Gifts To... TAT 2021 Honorary Award: A Recognition in Cancer Drug Development to...
